Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: Improvement with ilepatril treatment

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 8067-8074

  Davidson, Eric P ^b   Coppey, Lawrence J ^b   Yorek, Mark A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; ILEPATRIL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CILIARY ARTERY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA THICKNESS; DIABETIC NEUROPATHY; IMMUNOHISTOCHEMISTRY; INNERVATION; INSULIN DEPENDENT DIABETES MELLITUS; LACRIMATION; MALE; MOTOR NERVE CONDUCTION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEIVER OPERATING CHARACTERISTIC; SENSORY NERVE CONDUCTION; THERMAL EXPOSURE;

ACETYLCHOLINE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CILIARY ARTERIES; CRANIAL NERVE DISEASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EPITHELIUM, CORNEAL; HETEROCYCLIC COMPOUNDS, 3-RING; LIPIDS; MALE; OPHTHALMIC NERVE; PRODRUGS; RATS; RATS, SPRAGUE-DAWLEY; SENSATION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASODILATION; VASODILATOR AGENTS;

EID: 84873391854     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10826     Document Type: Article

References (35)

1. Tesfaye S, Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy? Curr Diab Rep. 2009;9:432-434.
2. Yorek MA. The potential role of angiotensin converting enzyme and vasopeptidase inhibitors in the treatment of diabetic neuropathy. Curr Drug Targets. 2008;9:77-84.
3. Quattrini C, Tavakoli M, Jeziorska M, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007;56:2148-2154.
4. Tavakoli M, Quattrini C, Abbott C, et al. Corneal confocal microscopy a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care. 2010;33:1792-1797.
5. Tavakoli M, Kallinikos P, Iqbal A, et al. Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet Med. 2011;28:1261-1267.
6. Malik RA, Kallinikos P, Abbott CA, et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003;46:683-688.
7. Tavakoli M, Hossain P, Malik RA. Clinical applications of corneal confocal microscopy. Clin Ophthalmol. 2008;2:435-445.
8. Yin J, Huang J, Chen C, Gao N, Wang F, Yu FS. Corneal complications in streptozotocin-induced type 1 diabetic rats. Invest Ophthalmol Vis Sci. 2011;52:6589-6596.
9. Davidson EP, Coppey LJ, Holmes A, Yorek MA. Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat. Invest Ophthalmol Vis Sci. 2012;53:1182-1187.
10. Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Dake B, Yorek MA. Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2011; 650:556-562.
11. Davidson EP, Kleinschmidt TL, Oltman CL, Lund DD, Yorek MA. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor, effect on vascular and neural disease. Diabetes. 2007;56:355-362.
12. Davidson EP, Coppey LJ, Holmes A, Dake B, Yorek MA. Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. Eur J Pharmacol. 2011;688:497-506.
13. Calcutt NA. Modeling diabetic sensory neuropathy in rats. Methods Mol Med. 2004;99:55-65.
14. Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Yorek MA. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin. Obesity. 2008;16:82-89.
15. Coppey LJ, Davidson EP, Dunlap J, Lund DD, Yorek MA. Slowing of motor nerve conduction velocity in streptozotocininduced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int J Exp Diabetes Res. 2000;1:131-143.
16. Obrosova IG, Li F, Abatan OI, et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes. 2004; 53:711-720.
17. Vagenas D, Pritchard N, Edwards K, et al. Optimal image sample size for corneal nerve morphometry. Optom Vis Sci. 2012;89:812-817.
18. Edwards K, Pritchard N, Vagenas D, Russell A, Malik RA, Efron N. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin Exp Optom. 2012;95:348-354.
19. Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care. 2007;30:2608-2612.
20. Pritchard N, Edwards K, Shahidi AM, et al. Corneal markers of diabetic neuropathy. Ocul Surf. 2011;9:17-28.
21. Terata K, Coppey LJ, Davidson EP, Dunlap JA, Gutterman DD, Yorek MA. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. Br J Pharmacol. 1999;128:837-843.
22. Hossain P, Sachdev A, Malik RA. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet. 2005;366:1340-1343.
23. Quattrini C, Tavakoli M, Jeziorska M, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007;56:2148-2154.
24. Pritchard N, Edwards K, Vagenas D, Russell AW, Malik RA, Efron N. Corneal sensitivity is related to established measures of diabetic peripheral neuropathy. Clin Exp Optom. 2012;95: 355-361.
25. Guthoff RF, Wienss H, Hahnel C, Wree A. Epithelial innervation of human cornea: a three-dimensional study using confocal laser scanning fluorescence microscopy. Cornea. 2005;24:608-613.
26. Muller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76:521-542.
27. Tavakoli M, Petropoulos IN, Malik RA. Assessing corneal nerve structure and function in diabetic neuropathy. Clin Exp Optom. 2012;95:338-347.
28. Malik RA. Early detection of nerve damage and repair in diabetic neuropathy. Nat Clin Pract Neurol. 2008;4:646-647.
29. Brussee V, Cunningham FA, Zochodne DW. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes. 2004;53:1824-1830.
30. Hayreh S. Posterior ciliary artery circulation in health and disease: the Weisenfeld lecture. Invest. Opthamol Vis Sci. 2004;45:749-757.
31. Bergua A, Schrodl F, Neuhuber WL. Vasoactive intestinal and calcitonin gene-related peptides, tyrosine hydroxylase and nitrergic markers in the innervation of the rat central retinal artery. Exp Eye Res. 2003;77:367-374.
32. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes. 2001;50:1927-1937.
33. Savaskan E, Loffler KU, Meier F, Muller-Spahn F, Flammer J, Meyer P. Immunohistochemical localization of angiotensinconverting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Res. 2004;36:312-320.
34. Kurihara T, Ozawa Y, Ishida S, Okano H, Tsubota K. Reninangiotensin system hyperactivation can induce inflammation and retinal neural dysfunction. Int J Inflam. 2012;2012: 581695.
35. Jeganathan VS. The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy. Curr Pharm Biotechnol. 2011;12:392-395.